NCT06822946 - Zhibitai Capsules for the Treatment of Primary Hyperlipidemia | Biotech Hunter

Enrollment

192

Participants

Timeline

Start Date

February 14, 2025

Primary Completion Date

February 28, 2026

Study Completion Date

April 30, 2026

Conditions

Primary Hyperlipidemia

Interventions

DRUG

zhibitai capsule

2 capsule of Zhibitai capsule/time, 2 times/day, oral

DRUG

zhibitai capsule

(1 capsule of Zhibitai capsules+1 capsule of Zhibitai capsule simulant)/time, 2 times/day, oral

Trial Locations (1)

Xiangya Second Hospital of Central South University, Changsha